GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation
出版年份 2022 全文链接
标题
GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation
作者
关键词
G protein-coupled receptors (GPCRs), Glucagon-like peptide 1, Glucose-dependent insulinotropic polypeptide, Beta cell, Insulin secretion, Incretin hormones, Co-agonist, Type 2 diabetes
出版物
PEPTIDES
Volume 151, Issue -, Pages 170749
出版商
Elsevier BV
发表日期
2022-01-20
DOI
10.1016/j.peptides.2022.170749
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonism
- (2021) Jason A. West et al. PLoS One
- Investigating GIPR (ant)agonism: A structural analysis of GIP and its receptor
- (2021) Florent X. Smit et al. STRUCTURE
- The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells
- (2021) Amaara Marzook et al. Frontiers in Endocrinology
- 87-LB: Binding Kinetics, Bias, Receptor Internalization, and Effects on Insulin Secretion for a Novel GLP1R-GIPR Dual Agonist, HISHS-2001
- (2021) YUSMAN MANCHANDA et al. DIABETES
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
- (2021) Bernhard Ludvik et al. LANCET
- Acylation of the incretin peptide exendin-4 directly impacts GLP-1 receptor signalling and trafficking
- (2021) Maria Lucey et al. MOLECULAR PHARMACOLOGY
- Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists
- (2021) Aaron Novikoff et al. Molecular Metabolism
- Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor
- (2021) Elita Yuliantie et al. BIOCHEMICAL PHARMACOLOGY
- No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes
- (2020) Natasha C. Bergmann et al. DIABETES CARE
- Dimerization/oligomerization of the extracellular domain of the GLP‐1 receptor and the negative cooperativity in its ligand binding revealed by the improved NanoBiT
- (2020) Xiaohan Song et al. FASEB JOURNAL
- Signalling, trafficking and glucoregulatory properties of glucagon‐like peptide‐1 receptor agonists exendin‐4 and lixisenatide
- (2020) Philip Pickford et al. BRITISH JOURNAL OF PHARMACOLOGY
- GIP as a therapeutic target in diabetes and obesity: insight from incretin co-agonists
- (2020) Jens Juul Holst et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials
- (2020) Matthew P. Gilbert et al. Frontiers in Endocrinology
- Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors
- (2020) Elita Yuliantie et al. BIOCHEMICAL PHARMACOLOGY
- GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1-Alpha Mutation Carriers
- (2020) Alexander S. Christensen et al. DIABETES
- How May GIP Enhance the Therapeutic Efficacy of GLP-1?
- (2020) Ricardo J. Samms et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
- (2020) Francis S. Willard et al. JCI Insight
- Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
- (2020) Elizabeth A. Killion et al. Nature Communications
- Discovery of a novel GLP-1/GIP dual receptor agonist CY-5 as long-acting hypoglycemic, anti-obesity agent
- (2020) Chunxia Liu et al. BIOORGANIC CHEMISTRY
- Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes
- (2020) Melissa K Thomas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
- (2020) Jonathan E. Campbell Molecular Metabolism
- The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
- (2020) Thinzar Min et al. Diabetes Therapy
- Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
- (2020) Geke Aline Boer et al. Biology-Basel
- Separate and Combined Gluco-Metabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 in Healthy Individuals
- (2019) Lærke S. Gasbjerg et al. DIABETES
- New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling
- (2019) Alejandra Tomas et al. JOURNAL OF MOLECULAR BIOLOGY
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential
- (2019) Marie Bastin et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- GIP’s involvement in the pathophysiology of type 2 diabetes
- (2019) Mikkel B. Christensen et al. PEPTIDES
- Molecular interactions of full-length and truncated GIP peptides with the GIP receptor – A comprehensive review
- (2019) Maria Buur Nordskov Gabe et al. PEPTIDES
- Human GIP(3-30)NH 2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors
- (2018) Maria Buur Nordskov Gabe et al. BIOCHEMICAL PHARMACOLOGY
- Glucagon-like peptide 1 in health and disease
- (2018) Andreas Andersen et al. Nature Reviews Endocrinology
- Structure and dynamics of GPCR signaling complexes
- (2018) Daniel Hilger et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Oxytocin is present in islets and plays a role in beta-cell function and survival
- (2018) Shruti Mohan et al. PEPTIDES
- Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men
- (2018) Patrik Rorsman et al. PHYSIOLOGICAL REVIEWS
- Chemical Strategies for Half-Life Extension of Biopharmaceuticals: Lipidation and Its Alternatives
- (2018) Esben M. Bech et al. ACS Medicinal Chemistry Letters
- Targeting GLP-1 receptor trafficking to improve agonist efficacy
- (2018) Ben Jones et al. Nature Communications
- Structure and dynamics of GPCR signaling complexes
- (2018) Daniel Hilger et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Peptide-based multi-agonists: a new paradigm in metabolic pharmacology
- (2018) Sara J. Brandt et al. JOURNAL OF INTERNAL MEDICINE
- Mechanisms of signalling and biased agonism in G protein-coupled receptors
- (2018) Denise Wootten et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models
- (2018) Elizabeth A. Killion et al. Science Translational Medicine
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
- (2018) Tamer Coskun et al. Molecular Metabolism
- Crystal structure of the GLP-1 receptor bound to a peptide agonist
- (2017) Ali Jazayeri et al. NATURE
- Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomes
- (2016) Sadek Ismail et al. BIOCHEMICAL PHARMACOLOGY
- The complexity of signalling mediated by the glucagon-like peptide-1 receptor
- (2016) Madeleine M. Fletcher et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor
- (2016) L S Hansen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Development of novel ligands for peptide GPCRs
- (2016) Brian M Moran et al. CURRENT OPINION IN PHARMACOLOGY
- Oligomerization of GPCRs involved in endocrine regulation
- (2016) Gunnar Kleinau et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Searching for the physiological role of glucose-dependent insulinotropic polypeptide
- (2016) Jens Juul Holst et al. Journal of Diabetes Investigation
- The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
- (2016) Michael A Nauck et al. Lancet Diabetes & Endocrinology
- Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway
- (2015) Aiysha Thompson et al. BIOCHEMICAL PHARMACOLOGY
- Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors
- (2015) A H Sparre-Ulrich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Structural Studies of G Protein-Coupled Receptors
- (2015) MOLECULES AND CELLS
- Glucose-Dependent Insulinotropic Polypeptide Augments Glucagon Responses to Hypoglycemia in Type 1 Diabetes
- (2014) Mikkel Christensen et al. DIABETES
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Functional Consequences of Glucagon-like Peptide-1 Receptor Cross-talk and Trafficking
- (2014) Sarah Noerklit Roed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- Real-time trafficking and signaling of the glucagon-like peptide-1 receptor
- (2013) Sarah Noerklit Roed et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans
- (2013) Stefan Amisten et al. PHARMACOLOGY & THERAPEUTICS
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
- (2013) B. Finan et al. Science Translational Medicine
- GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence
- (2012) A. R. Meloni et al. DIABETES OBESITY & METABOLISM
- Glucose-dependent insulinotropic polypeptide signaling in pancreatic β-cells and adipocytes
- (2012) Christopher HS McIntosh et al. Journal of Diabetes Investigation
- Systems analysis of GLP-1 receptor signaling in pancreatic β-cells
- (2011) Yukari Takeda et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans
- (2011) M. Christensen et al. DIABETES
- Activation of the GLP-1 Receptor Signalling Pathway: A Relevant Strategy to Repair a Deficient Beta-Cell Mass
- (2011) Bernard Portha et al. Experimental Diabetes Research
- Polymorphism and Ligand Dependent Changes in Human Glucagon-Like Peptide-1 Receptor (GLP-1R) Function: Allosteric Rescue of Loss of Function Mutation
- (2011) C. Koole et al. MOLECULAR PHARMACOLOGY
- GIP and GLP-1, the two incretin hormones: Similarities and differences
- (2010) Yutaka Seino et al. Journal of Diabetes Investigation
- Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?
- (2009) David J Grieve et al. BRITISH JOURNAL OF PHARMACOLOGY
- Exogenous Glucose-Dependent Insulinotropic Polypeptide Worsens Post prandial Hyperglycemia in T ype 2 Diabetes
- (2009) C. W. Chia et al. DIABETES
- Suppression of p38 MAPK and JNK via Akt-mediated Inhibition of Apoptosis Signal-regulating Kinase 1 Constitutes a Core Component of the β-Cell Pro-survival Effects of Glucose-dependent Insulinotropic Polypeptide
- (2009) Scott B. Widenmaier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The structure and function of G-protein-coupled receptors
- (2009) Daniel M. Rosenbaum et al. NATURE
- Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
- (2009) Bo Ahrén NATURE REVIEWS DRUG DISCOVERY
- GLP-1 receptor signaling: effects on pancreatic β-cell proliferation and survival
- (2008) J. Buteau DIABETES & METABOLISM
- Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes
- (2008) P. V. Højberg et al. DIABETOLOGIA
- Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
- (2008) P. V. Højberg et al. DIABETOLOGIA
- Pattern of Intra-Family Hetero-Oligomerization Involving the G-Protein-Coupled Secretin Receptor
- (2008) Kaleeckal G. Harikumar et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- -Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic cells
- (2008) N. Sonoda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started